NCT05786664 Breast Cancer Survivorship Biorepository
| NCT ID | NCT05786664 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Anatomic Stage I Breast Cancer AJCC v8 |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,300 participants |
| Start Date | 2022-04-11 |
| Primary Completion | 2027-04-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,300 participants in total. It began in 2022-04-11 with a primary completion date of 2027-04-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorepository for future use. The creation of this biorepository will allow for future research into links between individual, molecular, and genomic signatures and cancer outcomes.
Eligibility Criteria
Inclusion Criteria: * Women of all racial and ethnic groups 18 years of age or older * Women with a diagnosis of invasive breast cancer (stages I-III) within the past 7 years * Women who have completed active treatment for breast cancer (surgery, chemotherapy, HER2-directed therapy and radiation) * Prior participation on clinical trials is allowed Exclusion Criteria: * Current receipt of interventional clinical trial participation * Stage IV (metastatic) cancer * Prior history of recurrence (except recurrence following ductal carcinoma in situ) * Inability to give informed consent * Unable to speak English, Spanish, Chinese, or Korean
Contact & Investigator
Bodour Salhia, PhD
PRINCIPAL INVESTIGATOR
University of Southern California
Frequently Asked Questions
Who can join the NCT05786664 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Anatomic Stage I Breast Cancer AJCC v8. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05786664 currently recruiting?
Yes, NCT05786664 is actively recruiting participants. Contact the research team at amsaghia@usc.edu for enrollment information.
Where is the NCT05786664 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT05786664 clinical trial?
NCT05786664 is sponsored by University of Southern California. The principal investigator is Bodour Salhia, PhD at University of Southern California. The trial plans to enroll 1,300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.